Toxicity outcomes of concurrent radiotherapy with adjuvant capecitabine in triple-negative breast cancer (TROD 06-24)

Abstract Purpose Triple-negative breast cancer (TNBC), the subtype with the poorest prognosis, shows treatment outcomes closely tied to the response to neoadjuvant chemotherapy. Patients with residual disease post-treatment face a higher recurrence risk. In this subgroup, adjuvant capecitabine has b...

Descrición completa

Detalles Bibliográficos

Principais autores:	Volkan Demircan, Berrin Benli Yavuz, Bekir Hakan Bakkal, Sukran Celikarslan, Sule Karabulut Gul, Huseyin Tepetam, Didem Colpan Oksuz, Alaettin Arslan, Ayse Altinok
Formato:	Artigo
Idioma:	Inglês
Publicado:	Springer 2026-06-01
Series:	Discover Oncology
Assuntos:	Radiotherapy Capecitabine Triple negative breast cancer Side effects Toxicity
Acceso en liña:	https://doi.org/10.1007/s12672-026-05481-4
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!